RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Katalin Csiszar to Carcinoma, Squamous Cell

This is a "connection" page, showing publications Katalin Csiszar has written about Carcinoma, Squamous Cell.
Connection Strength

0.753
  1. G?r?gh T, Holtmeier C, Weise JB, Hoffmann M, Ambrosch P, Laudien M, Csiszar K. Functional analysis of the 5' flanking domain of the LOXL4 gene in head and neck squamous cell carcinoma cells. Int J Oncol. 2008 Nov; 33(5):1091-8.
    View in: PubMed
    Score: 0.297
  2. G?r?gh T, Weise JB, Holtmeier C, Rudolph P, Hedderich J, Gottschlich S, Hoffmann M, Ambrosch P, Csiszar K. Selective upregulation and amplification of the lysyl oxidase like-4 (LOXL4) gene in head and neck squamous cell carcinoma. J Pathol. 2007 May; 212(1):74-82.
    View in: PubMed
    Score: 0.268
  3. Martin A, Salvador F, Moreno-Bueno G, Florist?n A, Ruiz-Herguido C, Cuevas EP, Morales S, Santos V, Csiszar K, Dubus P, Haigh JJ, Bigas A, Portillo F, Cano A. Lysyl oxidase-like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression. EMBO J. 2015 Apr 15; 34(8):1090-109.
    View in: PubMed
    Score: 0.115
  4. Weise JB, Rudolph P, Heiser A, Kruse ML, Hedderich J, Cordes C, Hoffmann M, Brant O, Ambrosch P, Csiszar K, G?r?gh T. LOXL4 is a selectively expressed candidate diagnostic antigen in head and neck cancer. Eur J Cancer. 2008 Jun; 44(9):1323-31.
    View in: PubMed
    Score: 0.072
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support